Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gut permeability-guided antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis
ACTRN12618001039279Phase 4Not yet recruiting
- Sponsor
- Gastroenterology Department, The Queen Elizabeth Hospital
- Start
- Sep 2018
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of trimethoprim + sulfamethoxazole and ciprofloxacin in primary peritonitis (3 arms), sponsored by Gastroenterology Department, The Queen Elizabeth Hospital. Primary endpoint: Occurrence of spontaneous bacterial peritonitis. Planned start Sep 2018; status: not yet recruiting.
02
Drugs
trimethoprim + sulfamethoxazoleciprofloxacin
03
Conditions
primary peritonitis
Beyond the preview
Go deeper on ACTRN12618001039279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001039279.